Glenn Prestwich, PhD

Glenn D. Prestwich is currently the President’s Distinguished Professor at Washington State University, based at the WSU Health Sciences Spokane campus, founding director of WSU’s Entrepreneurial Faculty Ambassador program, and most recently founder and President of a new life sciences innovation hub, Spinout Space in Spokane, sp3nw. In September 2020, he was appointed as Science Innovation Advisor to HTL Biotechnology. He is Presidential Professor of Medicinal Chemistry (Emeritus) and Presidential Special Assistant for Faculty Entrepreneurism (Emeritus) at the University of Utah, where he created and led the Entrepreneurial Faculty Scholars program. He serves as the Chief Science Officer of the preclinical company GlycoMira Therapeutics. His research includes phospholipids in cell signaling, synthetic matrices for regenerative medicine, and anti-inflammatory glycosaminoglycans. He co-founded eleven companies, including Echelon Biosciences, Glycosan BioSystems, Sentrx Animal Care, GlycoMira Therapeutics, Deuteria Biomaterials, Clear Solutions Biomedical and Matrix Diagnostics Biosystems, and Maana Discoveries, and he advises several startups including Shasqi, Valitor, Modern Meadow, and others. He is a 2018 Fellow of the AAAS, a 2013 Fellow of the National Academy of Inventors, recipient of the 2006 Utah Governor’s Medal for Science and Technology, the 2008 Volwiler Research Award of the AACP, the 2010 University of Utah Distinguished Scholarly and Creative Research Award, and the 2014 U of Utah Distinguished Innovation and Impact Award. During his 42 years as a faculty member, he has over 665 publications (H-index 94) and over 48 issued patents and has trained over 125 postgraduate scientists. He is a pilot for Angel Flight West and a passionate advocate for chamber music.